Total Payments
$52,818
2024 Payments
$11,480
Companies
36
Transactions
114
Medicare Patients
1,959
Medicare Billing
$315,923
Payment Breakdown by Category
Consulting$35,473 (67.2%)
Food & Beverage$8,742 (16.6%)
Research$8,490 (16.1%)
Other$100.00 (0.2%)
Education$12.01 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,473 | 11 | 67.2% |
| Food and Beverage | $8,742 | 97 | 16.6% |
| Unspecified | $8,490 | 4 | 16.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $100.00 | 1 | 0.2% |
| Education | $12.01 | 1 | 0.0% |
Payments by Type
General
$44,327
110 transactions
Research
$8,490
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UROGEN PHARMA, INC. | $44,563 | 25 | $0 (2024) |
| Photocure Inc | $900.37 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $698.25 | 6 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $510.09 | 4 | $0 (2022) |
| Ethicon US, LLC | $506.93 | 5 | $0 (2022) |
| Myriad Genetic Laboratories, Inc. | $489.28 | 3 | $0 (2024) |
| Intuitive Surgical, Inc. | $443.37 | 7 | $0 (2020) |
| Blue Earth Diagnostics Limited | $435.46 | 4 | $0 (2024) |
| CONMED Corporation | $389.13 | 3 | $0 (2022) |
| BioTissue Holdings, Inc. | $360.87 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,480 | 19 | UROGEN PHARMA, INC. ($10,737) |
| 2023 | $10,966 | 25 | UroGen Pharma, Inc. ($9,417) |
| 2022 | $26,235 | 22 | UroGen Pharma, Inc. ($24,409) |
| 2021 | $927.60 | 9 | AstraZeneca Pharmaceuticals LP ($231.12) |
| 2020 | $1,012 | 10 | AstraZeneca Pharmaceuticals LP ($243.64) |
| 2019 | $1,202 | 15 | Photocure Inc ($542.18) |
| 2018 | $679.06 | 8 | Photocure Inc ($155.21) |
| 2017 | $315.39 | 6 | Astellas Pharma US Inc ($116.69) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $177.48 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/19/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $120.79 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: NONE | ||||||
| 11/09/2024 | Ferring Pharmaceuticals AS | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/10/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 07/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 05/20/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Urology Gynecology | ||||||
| 05/06/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $150.12 | General |
| Category: Immunotherapy | ||||||
| 04/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/26/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $6,923.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $104.05 | General |
| Category: Oncology | ||||||
| 03/19/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: Oncology | ||||||
| 03/13/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/04/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Urology Gynecology | ||||||
| 01/31/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: Urology | ||||||
| 01/16/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Diagnostic Imaging | ||||||
| 12/12/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $257.94 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $110.55 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | UroGen Pharma, Inc. | — | Food and Beverage | In-kind items and services | $213.72 | General |
| 11/30/2023 | UROGEN PHARMA, INC. | — | — | In-kind items and services | $213.72 | Research |
| Study: UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT) | ||||||
| 11/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $106.39 | General |
| Category: Oncology | ||||||
| 10/31/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: UROTHELIAL CANCER | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT) | UROGEN PHARMA, INC. | $8,490 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 474 | 1,691 | $522,909 | $89,521 |
| 2022 | 14 | 550 | 1,859 | $500,016 | $103,434 |
| 2021 | 15 | 568 | 2,029 | $475,640 | $85,949 |
| 2020 | 11 | 367 | 1,494 | $185,017 | $37,018 |
Total Patients
1,959
Total Services
7,073
Medicare Billing
$315,923
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 51999 | Other procedure on bladder using an endoscope | Facility | 2023 | 18 | 18 | $171,515 | $29,585 | 17.2% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 21 | 21 | $148,701 | $13,399 | 9.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 49 | 71 | $59,427 | $12,935 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 154 | $35,728 | $9,346 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 53 | $24,592 | $6,640 | 27.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $25,896 | $6,458 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 55 | $18,920 | $4,844 | 25.6% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 17 | 1,155 | $11,550 | $2,567 | 22.2% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 20 | 28 | $13,104 | $1,817 | 13.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,396 | $1,448 | 22.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 22 | 22 | $1,760 | $179.97 | 10.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 39 | 50 | $900.00 | $170.50 | 18.9% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 13 | 13 | $4,420 | $133.20 | 3.0% |
| 51999 | Other procedure on bladder using an endoscope | Facility | 2022 | 11 | 11 | $106,073 | $18,656 | 17.6% |
| A9589 | Instillation, hexaminolevulinate hydrochloride, 100 mg | Office | 2022 | 11 | 18 | $79,290 | $17,313 | 21.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 51 | 83 | $62,250 | $15,846 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 127 | $43,688 | $11,141 | 25.5% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 13 | 13 | $78,000 | $9,854 | 12.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 66 | 80 | $37,120 | $9,794 | 26.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 46 | 46 | $30,544 | $7,823 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 75 | $17,400 | $4,675 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $13,325 | $2,993 | 22.5% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2022 | 20 | 1,200 | $12,000 | $2,681 | 22.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 22 | 26 | $10,218 | $1,848 | 18.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 71 | 102 | $1,836 | $350.16 | 19.1% |
About Dr. Solomon Woldu, M.D
Dr. Solomon Woldu, M.D is a Urology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1518284462.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Solomon Woldu, M.D has received a total of $52,818 in payments from pharmaceutical and medical device companies, with $11,480 received in 2024. These payments were reported across 114 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($35,473).
As a Medicare-enrolled provider, Woldu has provided services to 1,959 Medicare beneficiaries, totaling 7,073 services with total Medicare billing of $315,923. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Dallas, TX
- Active Since 04/30/2010
- Last Updated 07/29/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518284462
Products in Payments
- JELMYTO (Drug) $19,186
- Cysview (Drug) $900.37
- LYNPARZA (Drug) $591.71
- PROVENGE (Drug) $510.09
- PROLARIS (Device) $489.28
- Da Vinci Surgical System (Device) $443.37
- AIRSEAL (Device) $389.13
- NEOX (Medical Supply) $360.87
- Axumin (Drug) $335.46
- Tulsa-Pro (Device) $303.50
- ORGOVYX (Drug) $255.83
- Enseal X1 (Device) $227.90
- INTERSTIM (Device) $174.70
- PLUVICTO (Drug) $160.62
- VISTASEAL (Biological) $153.95
- ANKTIVA (Drug) $150.12
- Rubraca (Drug) $133.17
- FOTIVDA (Drug) $131.50
- Olympus Cystoscopes (Device) $115.39
- LUTATHERA (Drug) $115.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Dallas
Dr. Allen Morey, Md, MD
Urology — Payments: $948,145
Urology $948,145
Dr. Vitaly Margulis, Md, MD
Urology — Payments: $524,117
Urology $524,117
Yair Lotan, Md, MD
Urology — Payments: $356,810
Urology $356,810
Claus Roehrborn, Md, MD
Urology — Payments: $288,665
Urology $288,665
Gary Lemack, Md, MD
Urology — Payments: $111,588
Urology $111,588
Samantha Nealon, M.d, M.D
Urology — Payments: $89,501
Urology $89,501